Modulateurs d'enzymes
Les modulateurs d'enzymes sont des composés qui peuvent augmenter ou inhiber l'activité des enzymes, régulant ainsi la vitesse des réactions biochimiques. Ces modulateurs jouent un rôle essentiel dans le contrôle des voies métaboliques, de la signalisation cellulaire et de divers processus physiologiques. Les modulateurs d'enzymes sont largement utilisés dans la recherche et le développement de médicaments pour étudier les fonctions enzymatiques et développer des agents thérapeutiques. Chez CymitQuimica, nous proposons une gamme complète de modulateurs d'enzymes de haute qualité pour soutenir vos recherches sur la régulation enzymatique et la découverte de médicaments.
Sous-catégories appartenant à la catégorie "Modulateurs d'enzymes"
693 produits trouvés pour "Modulateurs d'enzymes"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Mirodenafil dihydrochloride
CAS :<p>Mirodenafil dihydrochloride is a potent phosphodiesterase-5 (PDE5) inhibitor, which is a synthetic compound with a primarily chemical origin. Its mode of action involves the inhibition of the enzyme PDE5, which predominantly resides in the smooth muscle cells lining blood vessels. By inhibiting PDE5, Mirodenafil dihydrochloride effectively increases the levels of cyclic guanosine monophosphate (cGMP), leading to the relaxation of smooth muscle tissues and vasodilation.</p>Formule :C26H39Cl2N5O5SDegré de pureté :Min. 97 Area-%Couleur et forme :White PowderMasse moléculaire :604.59 g/molMefenamic acid
CAS :<p>COX1 inhibitor; blocker of Ca2+-activated non-selective cation channels</p>Formule :C15H15NO2Degré de pureté :Min. 99 Area-%Couleur et forme :White PowderMasse moléculaire :241.29 g/molMetformin HCl - Bio-X ™
CAS :<p>Metformin is a widely used anti-hyperglycemic (anti-diabetic) agent for the treatment of type 2 diabetes mellitus. This is due to it decreasing blood glucose by decreasing hepatic glucose product by activation of the AMP-activated protein kinase AMPK. Studies have also demonstrated Metformin to have anti-cancer activity, attributed to several mechanisms such as inhibition of mammalian target of rapamycin (mTOR), cancer stem cells and inflammation.</p>Formule :C4H11N5•HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :165.62 g/molLenvatinib mesylate - Bio-X ™
CAS :<p>Lenvatinib is an anti-cancer drug that is a multi-kinase inhibitor for VEGFR1, VEGFR2 and VEGFR. It has been shown to be effective against several cancers such as thyroid cancer and is currently in clinical trials for the treatment of leukaemia and prostate cancer. Furthermore, Lenvatinib also inhibits the activity of other protein kinases, including those involved in inflammatory responses.</p>Formule :C22H23ClN4O7SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :522.96 g/molPexidartinib
CAS :<p>Inhibitor of CSF1R receptor</p>Formule :C20H15ClF3N5Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :417.81 g/molTH 5487
CAS :<p>Specific inhibitor of 8-oxoguanine glycosylase OGG1 with IC50 in submicromolar range. The compound inhibits binding of OGG1 to its substrate 8-oxoguanine, a guanine analog generated in the presence of reactive oxygen species (ROS). It was shown that TH5487 decreases inflammation level by inhibiting the base excision DNA repair in mice and altering the OGG1 chromatin dynamics. The compound also has implications in cancer biology since OGG1 inhibitors sensitise tumours to chemotherapy.</p>Formule :C19BrH18IN4O2Degré de pureté :Min. 95%Couleur et forme :SolidMasse moléculaire :541.18 g/molPitavastatin lactone
CAS :<p>Inhibitor of HMG-CoA reductase</p>Formule :C25H22FNO3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :403.45 g/mol(R)-Lansoprazole
CAS :<p>Gastric proton pump inhibitor</p>Formule :C16H14F3N3O2SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :369.36 g/molN-ω-Propyl-L-arginine
CAS :<p>Neuronal selective nitric oxide synthase inhibitor</p>Formule :C9H20N4O2Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :216.28 g/molZoledronic acid, disodium salt, tetrahydrate
CAS :<p>Farnesyl pyrophosphate synthase inhibitor; hepatic de novo lipogenesis inhibitor</p>Formule :C5H8N2Na2O7P2·4H2ODegré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :388.11 g/molUNC 3230
CAS :<p>Inhibitor of PIP5K1C</p>Formule :C17H20N4O2SDegré de pureté :Min. 95%Couleur et forme :SolidMasse moléculaire :344.43 g/molIrinotecan hydrochloride trihydrate - Bio-X ™
CAS :<p>Irinotecan hydrochloride trihydrate is a topoisomerase I inhibitor that is used as chemotherapy drug for colorectal cancer. By inhibiting topoisomerase I, Irinotecan hydrochloride trihydrate prevents the replication of DNA in cells, and stops the cancer cells from growing and dividing. When used for chemotherapy, Irinotecan hydrochloride trihydrate is usually part of combination therapy with other chemotherapy drugs, such as 5-fluorouracil (5-FU) and leucovorin for other cancers.</p>Formule :C33H38N4O6•HCl•(H2O)3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :677.18 g/molLenvatinib base - Bio-X ™
CAS :<p>Lenvatinib is a tyrosine kinase inhibitor that is used to treat cancers such as solid tumours. This drug inhibits the activity of VEGR receptors. It also inhibits other receptors such as fibroblast growth factor.</p>Formule :C21H19ClN4O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :426.85 g/molTandutinib
CAS :<p>Tyrosine kinase inhibitor; antineoplastic activity; pro-apoptotic</p>Formule :C31H42N6O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :562.7 g/molVorinostat - Bio-X ™
CAS :<p>Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It is used to treat cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. This drug inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II).</p>Formule :C14H20N2O3Degré de pureté :Min. 99 Area-%Couleur et forme :PowderMasse moléculaire :264.32 g/molDarapladib
CAS :<p>Inhibitor of lipoprotein-associated phospholipase A2</p>Formule :C36H38F4N4O2SDegré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :666.77 g/molQuizartinib
CAS :<p>Inhibitor of FLT3 receptor tyrosine kinases; anti-neoplastic</p>Formule :C29H32N6O4SDegré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :560.67 g/molAzaserine
CAS :<p>Glutamine analogue and antagonist of glutamine-dependent amidotransferases, with antibiotic and antifungal properties. Inhibits purine biosynthesis, FGAM synthetase and glucosamine-6-phosphate isomerase that contributes to its antineoplastic property. Azaserine can also act as a carcinogen, by inducing DNA carboxymethylation. Protects endothelial cells from inflammation under hyperglycemic conditions, via antioxidant mechanisms, independent of hexosamine biosynthetic pathway.</p>Formule :C5H7N3O4Degré de pureté :Min. 98 Area-%Couleur et forme :Slightly Yellow PowderMasse moléculaire :173.13 g/mol(Z)-PugNAc
CAS :<p>Inhibitor of O-GlcNAcase and N-acetylhexosaminidases</p>Formule :C15H19N3O7Degré de pureté :Min. 97 Area-%Couleur et forme :White PowderMasse moléculaire :353.33 g/molAZ 960
CAS :<p>ATP competitive JAK2 inhibitor</p>Formule :C18H16F2N6Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :354.36 g/mol
